REGN Equity Ratio

Regeneron Pharmaceuticals · Equity Ratio

REGN logo

REGN Equity Ratio

Current (TTM)75.99%
REGN Equity Ratio (48.03% → 75.99%)
High-resolution chart · PNG

REGN equity ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Equity Ratio — Annual fiscal periods
Period endingEquity Ratio
77.0658%
77.7385%
78.5155%
77.5779%
73.7918%
64.2376%
74.9041%
74.6287%
70.1036%
63.8025%
65.1587%
65.6622%
66.1494%
59.8602%
36.6983%
48.4486%
53.5295%
62.5117%
49.1603%
37.024%
26.9189%
38.5838%
28.7022%
37.2806%
53.766%
87.4473%
79.927%
83.6201%
82.4822%
77.689%
72.3881%
71.2314%
83.6735%
89.0705%
93.1579%
48.0315%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.